Felipe Villalobos is a medical doctor graduated from the Universidad Autonoma Metropolitana in Mexico. Currently, he is a primary care researcher at the IDIAP Jordi Gol pin Barcelona, Spain, with a line of research in health promotion and preventive activities. Last five years, he has been coordinating vaccine safety and effectiveness studies using Real-World Data. He is a lecturer in the Faculty of Health Sciences at the Universitat Oberta de Catalunya, member of the European Health Parliament in the well-being for healthcare professionals committee, and coordinator of the International Society of Pharmacovigilance (ISoP) European Chapter.
This session explores the integration of SIDIAP (Sistema de Información para el Desarrollo de la Investigación en Atención Primaria), a Spanish health database, into the ConCEPTION Common Data Model (CDM). This initiative represents a significant advancement in vaccine safety research within the VAC4EU (Vaccine Monitoring Collaboration for Europe) Consortium. Managed by IDIAP Jordi Gol, SIDIAP contains comprehensive primary care data from over 5.8 million individuals in Catalonia, providing a robust platform for pharmacoepidemiologic investigations. Aligning SIDIAP with the ConCEPTION CDM standardizes its data, enabling interoperable, scalable, and reproducible research across diverse healthcare systems. This alignment enhances the capacity to detect and analyze vaccine-related adverse events effectively.
The presentation will detail the technical steps involved in this transformation, including data mapping, harmonization, validation, and the use of privacy-preserving Extract, Transform, Load (ETL) methodologies. It will also present case studies, such as analyses of adverse events following vaccination, to demonstrate the practical benefits of harmonized data for vaccine safety monitoring. This integration underscores the importance of standardized data models in bridging localized healthcare datasets with global research frameworks, supporting evidence-based public health decision-making, and fostering multinational collaboration in pharmacovigilance and pharmaepidemiology.